Home > Neurology > ECTRIMS 2021 > ECTRIMS 2021 Highlights Podcast

ECTRIMS 2021 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
Conference
ECTRIMS 2021
Trial
COMBAT-MS, SAkuraSky, SAkuraStar, ULTIMATE I and II, ORATORIO
In this episode (17:33 minutes), Medicom’s correspondent covers 6 presentations from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2021), held virtually from 13-15 October 2021 . The topics discussed are: 1.       Rituximab most effective initial MS therapy in Swedish real-world study In a comparative analysis of common initial MS therapies among Swedish MS patients in the COMBAT-MS study, rituximab demonstrated the lowest risk of relapses and MRI lesions. Furthermore, the lowest probability of switching therapy was observed for rituximab. Injectables demonstrated the highest probability of relapse and treatment discontinuation. 2.     


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on